Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Veeco
VECO
$1.52B
| $508K | ﹤0.01% |
27,710
-84,000
| -75% | -$1.54M |
|
|
USAP
2927
DELISTED
Universal Stainless & Alloy
USAP
| $508K | ﹤0.01% |
71,400
-18,028
| -20% | -$128K |
|
2928
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $507K | ﹤0.01% |
52,800
-152,700
| -74% | -$1.47M |
|
2929
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.48B
| $506K | ﹤0.01% |
+16,900
| New | +$506K |
|
2930
Genasys
GNSS
$99.3M
| $500K | ﹤0.01% |
180,542
-94
| -0.1% | -$260 |
|
2931
Kaltura
KLTR
$266M
| $500K | ﹤0.01% |
227,100
-258,711
| -53% | -$570K |
|
2932
Vanguard Financials ETF
VFH
$12.9B
| $499K | ﹤0.01% |
6,700
-4,600
| -41% | -$343K |
|
2933
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11.4B
| $498K | ﹤0.01% |
+11,300
| New | +$498K |
|
2934
Wave Life Sciences
WVE
$1.11B
| $498K | ﹤0.01% |
137,900
-25,700
| -16% | -$92.8K |
|
|
SAGE
2935
DELISTED
Sage Therapeutics
SAGE
| $497K | ﹤0.01% |
12,700
-30,700
| -71% | -$1.2M |
|
|
LILM
2936
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $496K | ﹤0.01% |
217,600
+150,400
| +224% | +$343K |
|
|
FFBW
2937
DELISTED
FFBW, Inc. Common Stock
FFBW
| $495K | ﹤0.01% |
41,626
-5,731
| -12% | -$68.2K |
|
2938
Pure Cycle
PCYO
$265M
| $493K | ﹤0.01% |
59,000
+9,400
| +19% | +$78.5K |
|
2939
Electromed
ELMD
$199M
| $491K | ﹤0.01% |
47,904
-13,000
| -21% | -$133K |
|
2940
Gannett
GCI
$620M
| $491K | ﹤0.01% |
320,924
+211,324
| +193% | +$323K |
|
2941
LegalZoom.com
LZ
$1.9B
| $490K | ﹤0.01% |
+57,142
| New | +$490K |
|
2942
Invesco NASDAQ Internet ETF
PNQI
$812M
| $489K | ﹤0.01% |
21,500
-4,500
| -17% | -$102K |
|
|
INVX
2943
Innovex International, Inc.
INVX
$1.14B
| $485K | ﹤0.01% |
24,859
+11,959
| +93% | +$233K |
|
2944
Tenaya Therapeutics
TNYA
$196M
| $482K | ﹤0.01% |
+166,200
| New | +$482K |
|
|
CALB
2945
DELISTED
California BanCorp Common Stock
CALB
| $479K | ﹤0.01% |
23,685
-1,900
| -7% | -$38.4K |
|
2946
Patrick Industries
PATK
$3.67B
| $478K | ﹤0.01% |
16,353
-85,650
| -84% | -$2.5M |
|
2947
OptimizeRx
OPRX
$322M
| $477K | ﹤0.01% |
32,200
-13,824
| -30% | -$205K |
|
2948
Village Farms International
VFF
$297M
| $477K | ﹤0.01% |
249,661
+6,111
| +3% | +$11.7K |
|
2949
SPDR S&P Regional Banking ETF
KRE
$4.24B
| $477K | ﹤0.01% |
8,100
-106,200
| -93% | -$6.25M |
|
2950
DexCom
DXCM
$29.9B
| $475K | ﹤0.01% |
5,900
-888,672
| -99% | -$71.5M |
|